C-MER MEDICAL completes on-market buyback of 100,000 shares, raises treasury stock to 25.23 million

Bulletin Express

Oct 08

Hong Kong-listed C-MER Medical Holdings Limited repurchased 100,000 ordinary shares on 8 October 2026 under its existing share-repurchase mandate approved on 20 May 2026. The transaction was executed on the Stock Exchange of Hong Kong at prices ranging between HKD 0.76 and HKD 0.775 per share, for a total consideration of HKD 0.08 million.

Following the buyback, C-MER Medical’s issued share capital (excluding treasury shares) declined by 0.0083 % to 1.20711 billion shares. Treasury shares increased from 25.13 million to 25.23 million, while the company’s total issued share count remained unchanged at 1.23234 billion.

The latest repurchase represents 0.0081 % of the 1.23 billion shares that shareholders authorised the company to repurchase (up to 123.23 million shares) at the May 2026 annual general meeting. All 100,000 shares bought on 8 October 2026 have been retained as treasury shares; none have been cancelled. Under Hong Kong Listing Rules, the company is subject to a moratorium on issuing, selling or transferring shares until 7 November 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hkg.itiger.com/news/1184398061"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1184398061\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1184398061?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-10-08 19:01","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1184398061","market":"us","top_or_hot":-1,"title":"C-MER MEDICAL completes on-market buyback of 100,000 shares, raises treasury stock to 25.23 million","media":"Bulletin Express","content":"<p>Hong Kong-listed C-MER Medical Holdings Limited repurchased 100,000 ordinary shares on 8 October 2026 under its existing share-repurchase mandate approved on 20 May 2026. The transaction was executed on the Stock Exchange of Hong Kong at prices ranging between HKD 0.76 and HKD 0.775 per share, for a total consideration of HKD 0.08 million.</p>\n<p>Following the buyback, C-MER Medical’s issued share capital (excluding treasury shares) declined by 0.0083 % to 1.20711 billion shares. Treasury shares increased from 25.13 million to 25.23 million, while the company’s total issued share count remained unchanged at 1.23234 billion.</p>\n<p>The latest repurchase represents 0.0081 % of the 1.23 billion shares that shareholders authorised the company to repurchase (up to 123.23 million shares) at the May 2026 annual general meeting. All 100,000 shares bought on 8 October 2026 have been retained as treasury shares; none have been cancelled. Under Hong Kong Listing Rules, the company is subject to a moratorium on issuing, selling or transferring shares until 7 November 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>C-MER MEDICAL completes on-market buyback of 100,000 shares, raises treasury stock to 25.23 million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nC-MER MEDICAL completes on-market buyback of 100,000 shares, raises treasury stock to 25.23 million\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-10-08 19:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Hong Kong-listed C-MER Medical Holdings Limited repurchased 100,000 ordinary shares on 8 October 2026 under its existing share-repurchase mandate approved on 20 May 2026. The transaction was executed on the Stock Exchange of Hong Kong at prices ranging between HKD 0.76 and HKD 0.775 per share, for a total consideration of HKD 0.08 million.</p>\n<p>Following the buyback, C-MER Medical’s issued share capital (excluding treasury shares) declined by 0.0083 % to 1.20711 billion shares. Treasury shares increased from 25.13 million to 25.23 million, while the company’s total issued share count remained unchanged at 1.23234 billion.</p>\n<p>The latest repurchase represents 0.0081 % of the 1.23 billion shares that shareholders authorised the company to repurchase (up to 123.23 million shares) at the May 2026 annual general meeting. All 100,000 shares bought on 8 October 2026 have been retained as treasury shares; none have been cancelled. Under Hong Kong Listing Rules, the company is subject to a moratorium on issuing, selling or transferring shares until 7 November 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03309","symbol_name":"希玛医疗","start_time":0,"source_url":"","article_id":"1184398061","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1184398061","pubTimestamp":1791457268,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Hong Kong-listed C-MER Medical Holdings Limited repurchased 100,000 ordinary shares on 8 October 2026 under its existing share-repurchase mandate approved on 20 May 2026. The transaction was executed...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03309":"希玛医疗"},"translate_title":"C-MER MEDICAL完成10万股场内回购，库存股增至2523万股","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03309":1},"content_text":"Hong Kong-listed C-MER Medical Holdings Limited repurchased 100,000 ordinary shares on 8 October 2026 under its existing share-repurchase mandate approved on 20 May 2026. The transaction was executed on the Stock Exchange of Hong Kong at prices ranging between HKD 0.76 and HKD 0.775 per share, for a total consideration of HKD 0.08 million.\nFollowing the buyback, C-MER Medical’s issued share capital (excluding treasury shares) declined by 0.0083 % to 1.20711 billion shares. Treasury shares increased from 25.13 million to 25.23 million, while the company’s total issued share count remained unchanged at 1.23234 billion.\nThe latest repurchase represents 0.0081 % of the 1.23 billion shares that shareholders authorised the company to repurchase (up to 123.23 million shares) at the May 2026 annual general meeting. All 100,000 shares bought on 8 October 2026 have been retained as treasury shares; none have been cancelled. Under Hong Kong Listing Rules, the company is subject to a moratorium on issuing, selling or transferring shares until 7 November 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}